Rebecca Mitchell, MD(@RebeccaCoelius) 's Twitter Profileg
Rebecca Mitchell, MD

@RebeccaCoelius

Investor and Product Doc at Clinicians who VC and @ViveCollective | Modern Brady Bunch family of 7 | Former Teladoc, Livongo, UCSF, HHS

ID:19734931

calendar_today29-01-2009 21:15:56

3,9K Tweets

2,9K Followers

1,6K Following

Rebecca Mitchell, MD(@RebeccaCoelius) 's Twitter Profile Photo

Great breakdown from Dhruv and IMO this also maps to what is and is not a venture backable TES company…

If the care model is not novel, and does not require or meaningfully benefit from novel enabling tech, I struggle to find the high risk/high reward angle.

Unless you are

account_circle
Laila Chima ✨(@lailachima) 's Twitter Profile Photo

How to pick the right startup in your early 20s

I semi-retired at 27 because I joined Stripe at a great time. Worth noting I know many people who have a lot more than me in pure $ value who don’t feel they can afford to take risks, and many who have a lot less but are more

account_circle
Rebecca Mitchell, MD(@RebeccaCoelius) 's Twitter Profile Photo

A delightful feature of a city like SF with many microclimates is how often you are tossed back years into strong sense memory.

In Duboce triangle today I was 20 again for a few minutes, late to take the train downtown but still crossed to the sunny side of the street to

account_circle
Dhruv Vasishtha(@dvasishtha) 's Twitter Profile Photo

In two weeks of running a native digital health talent form I've been able to connect ~20 candidates with founders and hiring managers for VP Product, CTO, Lead / Group PM, analytics engineer, and UX designer roles.

Reach out if you're hiring or interested in finding new opps!

account_circle
Jonathan Slotkin, MD(@slotkinjr) 's Twitter Profile Photo

This short clip is so important for any entrants that may not have a firm grasp yet on what is going to become commoditized

account_circle
Stuart Blitz(@StuartBlitz) 's Twitter Profile Photo

Whenever someone comments on your health startup “Yeah, but you just…”

Remember some large acquisitions/IPO’s in past years:

* Hims ($3B) “Just sells generic meds”
* One Medical ($3.9B) “Just a nicer PCP office w/ tech”
* Pillpack ($800M) “Just a different pill bottle”

account_circle
Rebecca Mitchell, MD(@RebeccaCoelius) 's Twitter Profile Photo

Fantastic example. And there are SO MANY supply/demand curves that could look different in healthcare. Every month+ wait, everything deferred or avoided because of cost and inconvenience.

account_circle
Dave Guarino (allafarce@hachyderm.io)(@allafarce) 's Twitter Profile Photo

There's such power in being able to recognize some things as *complicated*, which means they are reducible, tractable; you can get to the bottom, it's just work.

That's fundamentally different from *complex* things—you cannot know these things, only poke them and watch a bunch.

account_circle
Sandeep Palakodeti, MD MPH(@DrDeepMD) 's Twitter Profile Photo

What does “product” role mean to you in healthcare?

Is “clinical product” different than “tech product”?

What are some essential skills that clinicians working in product need to master?

Putting together a discussion around this w other healthcare leaders and would ❤️ input!

account_circle
Sandeep Palakodeti, MD MPH(@DrDeepMD) 's Twitter Profile Photo

Every doctor knows the system is irreparably broken. All of us call our colleagues, get special favors.

Then we tell patients to wait 6 months for next appointment...

But if it’s US or our families? Different story.

RebelHealthAlliance is how doctors want to receive care

account_circle
Brendan Keeler(@healthapiguy) 's Twitter Profile Photo

To say things as clearly as possible:

Carequality, Commonwell, eHealth Exchange, and TEFCA need to build the paved paths for non-Treatment purposes of use and require them. That's the end of it.

Simultaneously, the lack of action there doesn't enable or allow for the abuse of

account_circle
Rebecca Mitchell, MD(@RebeccaCoelius) 's Twitter Profile Photo

I just heard Epic shut Particle off from the HIEs. Widespread impact to Particle customers. Can anybody confirm or explain what’s going on? Brendan Keeler ?

account_circle
Rebecca Mitchell, MD(@RebeccaCoelius) 's Twitter Profile Photo

This is so important - I’m persistently guilty of putting this off, but Jon has convinced me to get it done for the sake of my family

account_circle
Rebecca Mitchell, MD(@RebeccaCoelius) 's Twitter Profile Photo

While true that ambient note taking will become a commodity capability, it is equally true that the companies currently winning on distribution are VASTLY better positioned to take on the next set of Gen AI in healthcare use cases. If you think they will own scribing and then sit

account_circle
@jason(@Jason) 's Twitter Profile Photo

One of the hardest things to face as a founder is moderate success…

… being able to hit a couple of million in revenue is really hard, and when you hit it and then have modest growth you’re trapped in the “in between” space.

This requires bold action: deprecating the

account_circle